Temporal and anatomic relationship between virus replication and cytokine gene expression after vaginal simian immunodeficiency virus infection

Journal of Virology

Volumn 79, Issue 19, 2005, Pages 12164-12172

  Abel, Kristina ^a,b,c   Rocke, David M ^a,b   Chohan, Barinderpal ^a,b   Fritts, Linda ^a,b   Miller, Christopher J ^a,b,c,d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; CD4 ANTIGEN; CYTOKINE;

ANATOMY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; GENE EXPRESSION; HETEROSEXUALITY; HUMAN IMMUNODEFICIENCY VIRUS; IMMUNE RESPONSE; IMMUNOSTIMULATION; INFLAMMATION; INOCULATION; INTESTINE; LYMPHOCYTE DEPLETION; LYMPHOID TISSUE; MUCOSAL IMMUNITY; NONHUMAN; PRIORITY JOURNAL; RHESUS MONKEY; SEXUAL TRANSMISSION; SIMIAN IMMUNODEFICIENCY VIRUS; T LYMPHOCYTE; TARGET CELL; VAGINITIS; VIRUS REPLICATION;

ANIMALS; CYTOKINES; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; INTERFERON-ALPHA; INTERFERON-BETA; KINETICS; LYMPHOID TISSUE; MACACA MULATTA; MUCOUS MEMBRANE; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SIMIAN IMMUNODEFICIENCY VIRUS; VAGINA; VIRUS REPLICATION;

MACACA MULATTA; SIMIAN IMMUNODEFICIENCY VIRUS;

EID: 25144479948     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.79.19.12164-12172.2005     Document Type: Article

References (49)

1. Abel, K., L. Compton, T. Rourke, D. Montefiori, D. Lu, K. Rothaeusler, L. Fritts, K. Best, and C. J. Miller. 2003. Simian-human immunodeficiency virus SHIV89.6-induced protection against intravaginal challenge with pathogenic SIVmac239 is independent of the route of immunization and is associated with a combination of cytotoxic T-lymphocyte and alpha interferon responses. J. Virol. 77:3099-3118.
2. Abel, K., L. La Franco-Scheuch, T. Rourke, Z. M. Ma, V. De Silva, B. Fallert, L. Beckett, T. A. Reinhart, and C. J. Miller. 2004. Gamma interferon-mediated inflammation is associated with lack of protection from intravaginal simian immunodeficiency virus SIVmac239 challenge in simian-Human immunodeficiency virus 89.6-immunized rhesus macaques. J. Virol. 78:841-854.
3. Ada, G. L., and P. D. Jones. 1986. The immune response to influenza infection. Curr. Top. Microbiol. Immunol. 128:1-54.
4. Andreakos, E., B. Foxwell, and M. Feldmann. 2004. Is targeting Toll-like receptors and their signaling pathway a useful therapeutic approach to modulating cytokine-driven inflammation? Immunol. Rev. 202:250-265.
5. Belardelli, F., and I. Gresser. 1996. The neglected role of type I interferon in the T-cell response: implications for its clinical use. Immunol. Today 17:369-372.
6. Binder, D., J. Fehr, H. Hengartner, and R. M. Zinkernagel. 1997. Virus-induced transient bone marrow aplasia: major role of interferon-alpha/beta during acute infection with the noncytopathic lymphocytic choriomeningitis virus. J. Exp. Med. 185:517-530.
7. Biron, C. A. 1998. Role of early cytokines, including alpha and beta interferons (IFN-alpha/beta), in innate and adaptive immune responses to viral infections. Semin. Immunol. 10:383-390.
8. Bouma, G., and W. Strober. 2003. The immunological and genetic basis of inflammatory bowel disease. Nat. Rev. Immunol. 3:521-533.
9. Bouscarat, F., M. Levacher, M. C. Dazza, F. Chau, B. Desforges, M. Muffat-Joly, S. Matheron, P. M. Girard, and M. Sinet. 1999. Prospective study of CD8+ lymphocyte activation in relation to viral load in HIV-infected patients with ≥400 CD4+ lymphocytes per microliter. AIDS Res. Hum. Retrovir. 15:1419-1425.
10. Brinkmann, V., T. Geiger, S. Alkan, and C, H. Heusser. 1993. Interferon alpha increases the frequency of interferon gamma-producing human CD4+ T cells. J. Exp. Med. 178:1655-1663.
11. Broussard, S. R., S. I. Staprans, R. White, E. M. Whitehead, M. B. Feinberg, and J. S. Allan. 2001. Simian immunodeficiency virus replicates to high levels in naturally infected African green monkeys without inducing immunologic or neurologic disease. J. Virol. 75:2262-2275.
12. Conn, C. A., J. L. McClellan, H. F. Maassab, C. W. Smitka, J. A. Majde, and M. J. Kluger. 1995. Cytokines and the acute phase response to influenza virus in mice. Am. J. Physiol. 268:R78-R84.
13. Daig, R., T. Andus, E. Aschenbrenner, W. Falk, J. Scholmerich, and V. Gross. 1996. Increased interleukin 8 expression in the colon mucosa of patients with inflammatory bowel disease. Gut 38:216-222.
14. Dailey, P. J., M. Zamround, R. Kelso, J. Kolberg, and M. Urdea. 1995. Quantitation of simian immunodeficiency virus (SIV) RNA in plasma of acute and chronically infected macaques using a branched DNA (bDNA) signal amplification assay. J. Med. Primatol. 24:209.
15. Durbin, J. E., A. Fernandez-Sesma, C. K. Lee, T. D. Rao, A. B. Frey, T. M. Moran, S. Vukmanovic, A. Garcia-Sastre, and D. E. Levy. 2000. Type I IFN modulates innate and specific antiviral immunity. J. Immunol. 164:4220-4228.
16. Garber, D. A., G. Silvestri, A. P. Barry, A. Fedanov, N. Kozyr, H. McClure, D. C. Montefiori, C. P. Larsen, J. D. Altman, S. I. Staprans, and M. B. Feinberg. 2004. Blockade of T cell costimulation reveals interrelated actions of CD4+ and CD8+ T cells in control of SIV replication. J. Clin. Investig. 113:836-845.
17. Gibson, P., and O. Rosella. 1995. Interleukin 8 secretion by colonie crypt cells in vitro: response to injury suppressed by butyrate and enhanced in inflammatory bowel disease. Gut 37:536-543.
18. Giorgi, J. V., and R. Detels. 1989. T-cell subset alterations in HIV-infected homosexual men: NIAID Multicenter AIDS cohort study. Clin. Immunol. Immunopathol. 52:10-18.
19. Greenier, J. L., C. J. Miller, D. Lu, P. J. Dailey, F. X. Lu, K. J. Kunstman, S. M. Wolinsky, and M. L. Marthas. 2001. Route of simian immunodeficiency virus inoculation determines the complexity but not the identity of viral variant populations that infect rhesus macaques. J. Virol. 75:3753-3765.
20. Guha-Thakurta, N., and J. A. Majde. 1997. Early induction of proinflammatory cytokine and type I interferon mRNAs following Newcastle disease virus, poly [rI:rC], or low-dose LPS challenge of the mouse. J. Interferon Cytokine Res. 17:197-204.
21. Guimbaud, R., V. Bertrand, L. Chauvelot-Moachon, G. Quartier, N. Vidon, J. P. Giroud, D. Couturier, and S. Chaussade. 1998. Network of inflammatory cytokines and correlation with disease activity in ulcerative colitis. Am. J. Gastroenterol. 93:2397-2404.
22. Heremans, H., A. Billiau, and P. De Somer. 1980. Interferon in experimental viral infections in mice: tissue interferon levels resulting from the virus infection and from exogenous Interferon therapy. Infect. Immun. 30:513-522.
23. Ho, D. D. 1995. HIV-1 dynamics in vivo. J. Biol. Regul. Homeost. Agents 9:76-77.
24. Kaur, A., R. M. Grant, R. E. Means, H. McClure, M. Feinberg, and R. P. Johnson. 1998. Diverse host responses and outcomes following simian immunodeficiency virus SIVmac239 infection in sooty mangabeys and rhesus macaques. J. Virol. 72:9597-9611.
25. Khatissian, E., M. G. Tovey, M. C. Cumont, V. Monceaux, P. Lebon, L. Montagnier, B. Hurtrel, and L. Chakrabarti. 1996. The relationship between the interferon alpha response and viral burden in primary SIV infection. AIDS Res. Hum. Retrovir. 12:1273-1278.
26. Kuroda, M. J., J. E. Schmitz, W. A. Charini, C. E. Nickerson, M. A. Lifton, C. I. Lord, M. A. Forman, and N. L. Letvin. 1999. Emergence of CTL coincides with clearance of virus during primary simian immunodeficiency virus infection in rhesus monkeys. J. Immunol. 162:5127-5133.
27. La Bonnardiere, C., and H. Laude. 1983. Interferon induction in rotavirus and coronavirus infections: a review of recent results. Ann. Rech. Vet. 14:507-511.
28. Levacher, M., F. Hulstaert, S. Tallet, S. Ullery, J. J. Pocidalo, and B. A. Bach. 1992. The significance of activation markers on CD8 lymphocytes in human immunodeficiency syndrome: staging and prognostic value. Clin. Exp. Immunol. 90:376-382.
29. Li, Q., L. Duan, J. D. Estes, Z. M. Ma, T. Rourke, Y. Wang, C. Reilly, J. Carlis, C. J. Miller, and A. T. Haase. 2005. Peak SIV replication in resting memory CD4+ T cells depletes gut lamina propria CD4+ T cells. Nature 434:1148-1152.
30. Mandell, C. P., N. C. Jain, C. J. Miller, and S. Dandekar. 1995. Bone marrow monocyte/macrophages are an early cellular target of pathogenic and non-pathogenic isolates of simian immunodeficiency virus (SIVmac) in rhesus macaques. Lab. Investig. 72:323-333.
31. Mattapallil, J. J., D. C. Douek, B. Hill, Y. Nishimura, M. Martin, and M. Roederer. 2005. Massive infection and loss of memory CD4+ T cells in multiple tissues during acute SIV infection. Nature 434:1093-1097.
32. Miller, C. J., Q. Li, K. Abel, E.-Y. Kim, M. Ma, S. Wietgrefe, L. LaFranco-Scheuch, L. Compton, L. Duan, M. Dykhulzen-Shore, M. Zupancic, M. Busch, J. Carlis, S. M. Wolinsky, and A. T. Haase. 2005. Propagation and dissemination of infection after vaginal transmission of simian immunodeficiency virus. J. Virol. 79:9217-9227.
33. Muller, U., U. Steinhoff, L. F. Reis, S. Hemmi, J. Pavlovic, R. M. Zinkernagel, and M. Aguet. 1994. Functional role of type I and type II interferons in antiviral defense. Science 264:1918-1921.
34. O'Neil, S. P., F. J. Novembre, A. B. Hill, C. Suwyn, C. E. Hart, T. Evans-Strickfaden, D. C. Anderson, J. deRosayro, J. G. Herndon, M. Saucier, and H. M. McClure. 2000. Progressive infection in a subset of HIV-1-positive chimpanzees. J. Infect. Dis. 182:1051-1062.
35. Paiardini, M., B. Cervasi, R. Dunham, B. Sumpter, H. Radziewicz, and G. Silvestri. 2004. Cell-cycle dysregulation in the immunopathogenesis of AIDS. Immunol. Res. 29:253-268.
36. + T-lymphocyte response to major immunodominant epitopes after vaginal exposure to simian immunodeficiency virus: too late and too little. J. Virol. 79:9228-9235.
37. Richman, D. D., B. R. Murphy, S. Baron, and C. Uhlendorf. 1976. Three strains of influenza A virus (H3N2): interferon sensitivity in vitro and interferon production in volunteers. J. Clin. Microbiol. 3:223-226.
38. Santini, S. M., C. Lapenta, M. Logozzi, S. Parlato, M. Spada, T. Di Pucchio, and F. Belardelli. 2000. Type I interferon as a powerful adjuvant for monocyte-derived dendritic cell development and activity in vitro and in Hu-PBL-SCID mice. J. Exp. Med. 191:1777-1788.
39. Savarino, A., F. Bottarel, F. Malavasi, and U. Dianzani. 2000. Role of CD38 in HIV-1 infection: an epiphenomenon of T-cell activation or an active player in virus/host interactions? AIDS 14:1079-1089.
40. Selam, B., U. A. Kayisli, J. A. Garcia-Velasco, G. E. Akbas, and A. Arici. 2002. Regulation of fas ligand expression by IL-8 in human endometrium. J. Clin. Endocrinol. Metab. 87:3921-3927.
41. Silvestri, G., D. L. Sodora, R. A. Koup, M. Paiardini, S. P. O'Neil, H. M. McClure, S. I. Staprans, and M. B. Feinberg. 2003. Nonpathogenic SIV infection of sooty mangabeys is characterized by limited bystander immunopathology despite chronic high-level viremia. Immunity 18:441-452.
42. Sopper, S, D. Nierwetberg, A. Halbach, U. Sauer, C. Scheller, C. Stahl-Hennig, K. Matz-Rensing, F. Schafer, T. Schneider, V. ter Meulen, and J. G. Muller. 2003. Impact of simian immunodeficiency virus (SIV) infection on lymphocyte numbers and T-cell turnover in different organs of rhesus monkeys. Blood 101:1213-1219.
43. Uguccioni, M., P. Gionchetti, D. F. Robbiani, F. Rizzello, S. Peruzzo, M. Campieri, and M. Baggiolini. 1999. Increased expression of IP-10, IL-8, MCP-1, and MCP-3 in ulcerative colitis. Am. J. Pathol. 155:331-336.
44. Vajdy, M., R. Veazey, I. Tham, C. deBakker, S. Westmorland, M. Neutra, and A. Lackner. 2001. Early immunologic events in mucosal and systemic lymphoid tissues after intrarectal inoculation with simian immunodeficiency virus. J. Infect. Dis. 184:1007-1014.
45. van den Broek, M. F., U. Muller, S. Huang, M. Aguet, and R. M. Zinkernagel. 1995. Antiviral defense in mice lacking both alpha/beta and gamma interferon receptors. J. Virol. 69:4792-4796.
46. van den Broek, M. F., U. Muller, S. Huang, R. M. Zinkernagel, and M. Aguet. 1995. Immune defence in mice lacking type I and/or type II interferon receptors. Immunol. Rev. 148:5-18.
47. Veazey, R., and A. Lackner. 2003. The mucosal immune system and HIV-1 infection. AIDS Rev. 5:245-252.
48. Veazey, R. S., P. A. Marx, and A. A. Lackner. 2001. The mucosal immune system: primary target for HIV infection and AIDS. Trends Immunol. 22: 626-633.
49. Yamaoka-Tojo, M., S. Yamaguchi, J. Nitobe, S. Abe, S. Inoue, N. Nozaki, M. Okuyama, M. Sata, I. Kubota, H. Nakamura, and H. Tomoike. 2003. Dual response to Fas ligation in human endothelial cells: apoptosis and induction of chemokines, interleukin-8 and monocyte chemoattractant protein-1. Coron. Artery Dis. 14:89-94.